Four years ago, Fonar was basking in the glow of its $100-million-plus legal victory over GE in a patent issue. Whatever is left from that court battle, however, apparently is not enough. The Tail Wind Fund, which focuses on emerging growth companies,
Four years ago, Fonar was basking in the glow of its $100-million-plus legal victory over GE in a patent issue. Whatever is left from that court battle, however, apparently is not enough. The Tail Wind Fund, which focuses on emerging growth companies, has invested $4.5 million in Fonar, receiving in exchange debentures convertible to Fonar common stock. Fonar issued two series of warrants to the fund. It will file details of the transaction with the SEC. The newfound capital will be used to fund the production of Fonar’s line of MRI devices, including its Indomitable, a stand-up MRI scanner optimized for orthopedic imaging. The company announced earlier this month the sale of an Indomitable to the University of Aberdeen in Scotland.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.